The conclusion is made that the novel mechanism by which circSCMH1 downregulates KMO expression was revealed and that such role of circSCMH1 in promoting stroke recovery makes it a therapeutic target for the treatment of ischemic stroke. The gene discussed is KMO; the disease is stroke disorder.